Chemical Research in Toxicology is a premier journal published by the American Chemical Society, dedicated to advancing the understanding of toxicological effects associated with chemical substances. Since its inception in 1988, this esteemed journal has maintained a robust impact factor, ranking in the Q1 quartile for both Medicine (miscellaneous) and Toxicology as of 2023, reflecting its significance and influence in the fields of pharmacology and toxicology. With an impressive Scopus ranking at #16 out of 133 in the Toxicology category, it serves as a vital resource for researchers, professionals, and students seeking cutting-edge insights and scholarly articles that bridge the gap between chemistry and toxicological science. Although not an open-access publication, it continues to provide comprehensive analyses and original research that inform safe chemical practices and regulatory policies, further enhancing its role in public health and safety.

Toxicological Research is a prominent academic journal dedicated to advancing the field of toxicology through rigorous exploration and innovative research. Published by the Korean Society of Toxicology, this journal serves as a vital resource for researchers, professionals, and students engaged in environmental science, pharmacology, and toxicology. With an ISSN of 1976-8257 and an E-ISSN of 2234-2753, Toxicological Research highlights significant findings and discussions in the realm of health, toxicology, and mutagenesis. Although not an open-access journal, it maintains a solid reputation as evidenced by its Q3 ranking in both health-related toxicology and general toxicology categories for 2023. The journal covers a broad spectrum of topics from fundamental research to applied toxicology and provides a unique platform for the dissemination of knowledge in a field that is increasingly relevant in today’s society. With an anticipated convergence period from 2008 to 2024, Toxicological Research continues to contribute vital insights to understanding the implications of toxic substances on health and the environment.

TOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.

TOXICOLOGY IN VITRO is a premier journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest advancements in the field of toxicology, particularly through in vitro methodologies. With an ISSN of 0887-2333 and an E-ISSN of 1879-3177, this journal serves as a critical platform for researchers aiming to disseminate their findings in toxicology, emphasizing innovative approaches and applications in pharmacology and toxicology. Featuring a commendable impact factor and classified in the second quartile (Q2) for both Medicine (miscellaneous) and Toxicology in 2023, the journal holds a significant position within the academic community, ranking 41st out of 133 in the Toxicology category according to Scopus, representing the 69th percentile. Despite being a subscription-based publication, it continuously attracts submissions from leading scientists worldwide, fostering a vibrant exchange of scientific knowledge. Since its inception in 1987, TOXICOLOGY IN VITRO has consistently aimed to enhance understanding of toxicological challenges, making it an invaluable resource for professionals, students, and researchers dedicated to developing safer pharmaceuticals and understanding the biological pathways influenced by potential toxic agents.

PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.

REPRODUCTIVE TOXICOLOGY, published by Pergamon-Elsevier Science Ltd, stands as a pivotal journal in the field of toxicology, specifically focusing on the effects of environmental and pharmaceutical agents on reproductive health. Established in 1987, the journal has a rich history of contributing to the scientific community, and it continues to publish rigorous research and reviews that illuminate the intricate relationships between various toxicants and their reproductive impacts. With an impressive 2023 Q2 ranking in Toxicology and a Scopus ranking of #42 out of 133 in the Toxicology category, REPRODUCTIVE TOXICOLOGY emphasizes high-quality scholarly work that influences both academia and industry practices. Researchers, professionals, and students in toxicology, pharmacology, and public health will find this journal an invaluable resource for staying informed on the latest findings and methodologies in reproductive toxicology. While the journal currently adheres to traditional publishing models without open access options, its authoritative content remains accessible to a global audience interested in advancing the understanding of toxicological impacts on reproduction.

Inhalation Toxicology, published by Taylor & Francis Ltd, is a premier journal dedicated to advancing the field of toxicology with a particular focus on inhalation exposure and its impact on human health. Established in 1989, this journal provides a vital platform for original research, reviews, and case studies that explore the toxicological effects of inhaled substances, making it essential reading for researchers, health professionals, and regulatory scientists. With an Impact Factor that situates it in the Q3 category in both Health, Toxicology and Mutagenesis, the journal asserts its relevance within the scientific community, particularly emphasizing its contributions as indexed by Scopus rankings in related fields. Although it follows a traditional access model, the journal's commitment to delivering high-quality research continues to foster significant discussions and advancements in understanding inhalation toxicology. For those at the forefront of environmental science and pharmacology, Inhalation Toxicology is an indispensable resource for both current research and future innovations in the discipline.

Drug and Chemical Toxicology is a well-respected journal in the fields of toxicology, pharmacology, and public health, published by Taylor & Francis Ltd. Since its inception in 1978, this journal has diligently explored the effects and mechanisms of chemical exposures on health and the environment, fulfilling a crucial role in advancing scientific understanding and safeguarding public health. The journal is indexed across prestigious databases and features an impressive array of articles categorized within the Q2 and Q3 quartiles across various categories in 2023, reflecting its significance in Chemical Health and Safety as well as Environmental and Occupational Health disciplines. With an extensive reach and a focus on interdisciplinary research, Drug and Chemical Toxicology offers a rich repository of original research, reviews, and methodological advancements, catering to a diverse audience of researchers, professionals, and students dedicated to the betterment of safety and health standards. Although not an open-access publication, its articles are widely accessible to the academic community, ensuring that critical innovations and insights are shared for the greater good.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.

Particle and Fibre Toxicology is a leading open-access journal dedicated to advancing the field of toxicology, specifically focusing on the health impacts of particulate matter and fibers. Published by BMC since 2004, this journal operates from its offices in the United Kingdom and has gained significant recognition in the scientific community, achieving an impressive impact factor that highlights its relevance and influence. As indicated by its Q1 ranking in various categories including Health, Toxicology and Mutagenesis and Medicine (miscellaneous), it occupies a prestigious position in the academic landscape, appealing to researchers, professionals, and students alike. With a Scopus ranking of #4 in Toxicology and #7 in Environmental Science, the journal ensures high visibility and accessibility, providing a platform for the dissemination of key research findings and innovative methodologies in the interdisciplinary domains of toxicology. Through its commitment to open access, Particle and Fibre Toxicology fosters knowledge-sharing and collaboration, facilitating significant advancements in our understanding of the toxicological effects of environmental agents.